Outset Medical, Inc. (OM)
| Market Cap | 2.09B |
| Revenue (ttm) | 39.77M |
| Net Income (ttm) | -108.89M |
| Shares Out | 12.30M |
| EPS (ttm) | -8.85 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | February 25 |
| Last Price | $49.53 |
| Previous Close | $50.22 |
| Change ($) | -0.69 |
| Change (%) | -1.37% |
| Day's Open | 50.26 |
| Day's Range | 48.00 - 51.00 |
| Day's Volume | 117,928 |
| 52-Week Range | 42.50 - 66.96 |
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind device to reduce the cost and complexity of dialysi...
Discover how Outset Medical is making dialysis easier and cheaper.
LONDON--(BUSINESS WIRE)--Deep Pharma Intelligence names Nanox Imaging (NASDAQ:NNOX), TransMedics, Inc. (NASDAQ: TMDX), Outset Medical, Inc. (NASDAQ:OM), Eargo, Inc. (NASDAQ:EAR), and Silk Road...
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dia...
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical Announces Secondary Offering of Common Stock
Outset Medical is performing in line with my expectations which I outlined at the time of the public offering. I look forward to the contribution from the home market in 2021, expected to have...
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dia...
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dia...
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dia...
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dia...
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dia...
Outset Medical: Very Interesting MedTech Growth Play
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc.
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”) today announced the pricing of its upsized initial public offering of 8,951,111 shares of its common stock at a ...
About OM
Outset Medical, a medical technology company, develops a hemodialysis system for dialysis. It offers Tablo, a dialysis machine that enables dialysis care in acute and chronic settings. The Tablo comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
| Industry Medical Devices | IPO Date Sep 15, 2020 |
| CEO Leslie L. Trigg | Employees 284 |
| Stock Exchange NASDAQ | Ticker Symbol OM |
Financial Performance
In 2019, Outset Medical's revenue was $15.08 million, an increase of 651.27% compared to the previous year's $2.01 million. Losses were -$68.30 million, 37.2% more than in 2018.
Analyst Forecasts
According to 6 analysts, the average rating for Outset Medical stock is "Buy." The 12-month stock price forecast is 58.40, which is an increase of 17.91% from the latest price.